MoonLake Immunotherapeutics
MLTX | NASDAQ
$12.98
+$0.43 (+3.43%)
Sep 22, 2026, 11:34 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.6M | 2.34M | 1.49M | 742K | 774.52K | 32.52K | 32.52K | 32.52K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.49K | 2.49K | 2.49K | 2.49K | n/a | n/a | n/a |
Gross Profit | -1.6M | -2.34M | -1.49M | -742K | -774.52K | -32.52K | -32.52K | -32.52K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.49K | -2.49K | -2.49K | -2.49K | n/a | n/a | n/a |
Operating Income | -268.34M | -267.37M | -244.84M | -229.2M | -200.88M | -170.76M | -143.09M | -108.54M | -78.4M | -61.01M | -54.12M | -55.79M | -57.58M | -62.05M | -65.06M | -62.64M | -54.14M | -69.17M | -53.32M | -39.14M | -32.88M | -194.86K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17.82K | 32.73K | 32.73K | 32.73K |
Pretax Income | -264.15M | -258.39M | -229.71M | -213.3M | -178.74M | -147.46M | -120.96M | -82.45M | -58.02M | -45.68M | -43.98M | -52.6M | -55.74M | -60.8M | -64.47M | -62.33M | -53.88M | -69.16M | -53.36M | -39.14M | -32.85M | -162.13K |
Net Income | -263.67M | -257.08M | -227.32M | -210.5M | -176.16M | -145.21M | -118.93M | -80.77M | -54.8M | -40.68M | -36.01M | -30.51M | -31.19M | -33.17M | -40.05M | -52.43M | -48.61M | -69.17M | -53.37M | -39.14M | -32.85M | -162.13K |
Selling & General & Admin | 46.96M | 46.46M | 41.97M | 41.98M | 38.56M | 34.54M | 30.32M | 28.03M | 26.04M | 23.61M | 22.32M | 20.72M | 21.07M | 22.84M | 22.81M | 26.77M | 26.62M | 23.18M | 17.79M | 8.61M | 3.01M | 194.86K |
Research & Development | 222.02M | 220.82M | 203.61M | 186.47M | 161.54M | 136.18M | 112.74M | 80.48M | 52.36M | 37.4M | 31.8M | 35.07M | 36.51M | 39.21M | 42.25M | 35.87M | 27.52M | 45.98M | 35.53M | 30.54M | 29.87M | n/a |
Other Expenses | -2.24M | -2.24M | -2.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 266.74M | 265.04M | 243.34M | 228.46M | 200.1M | 170.72M | 143.06M | 108.51M | 78.4M | 61.01M | 54.12M | 55.79M | 57.58M | 62.05M | 65.06M | 62.64M | 54.14M | 69.17M | 53.32M | 39.14M | 32.88M | 194.86K |
Interest Expense | 10.09M | 9.5M | 7.25M | 5.25M | 2.06M | 18K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 268.34M | 267.37M | 244.83M | 229.2M | 200.88M | 170.76M | 143.09M | 108.54M | 78.4M | 61.01M | 54.12M | 55.79M | 57.58M | 62.05M | 65.06M | 62.64M | 54.14M | 69.17M | 53.32M | 39.14M | 32.88M | 194.86K |
Income Tax Expense | 1.08M | 1.08M | 611K | 404.14K | 381.25K | 365.25K | 282.25K | 285.41K | 222.23K | 153.38K | 94.39K | 61.09K | 40.91K | 40.04K | 36.37K | 30.11K | 21.37K | 12.09K | 4.76K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 73.92M | 71.27M | 64.46M | 63.37M | 63.28M | 63.23M | 63.07M | 62.9M | 62.87M | 62.64M | 59.91M | 53.52M | 43.72M | 39.06M | 38.84M | 36.93M | 35.2M | 36.93M | 36.93M | 36.93M | 36.93M | 14.81M |
Shares Outstanding (Diluted) | 73.92M | 71.27M | 64.46M | 63.37M | 63.28M | 63.23M | 63.07M | 62.9M | 62.87M | 62.64M | 59.91M | 53.52M | 43.72M | 39.06M | 38.84M | 36.93M | 35.2M | 36.93M | 36.93M | 36.93M | 36.93M | 14.81M |
EPS (Basic) | -3.85 | -3.88 | -3.53 | -3.32 | -2.78 | -2.30 | -1.89 | -1.29 | -0.91 | -0.75 | -0.84 | -0.77 | -0.99 | -1.25 | -1.37 | -1.38 | -1.15 | -1.55 | -1.13 | -1.07 | -0.90 | -0.01 |
EPS (Diluted) | -3.85 | -3.88 | -3.53 | -3.32 | -2.78 | -2.30 | -1.89 | -1.29 | -0.91 | -0.75 | -0.84 | -0.77 | -0.99 | -1.25 | -1.37 | -1.38 | -1.15 | -1.55 | -1.13 | -1.07 | -0.90 | -0.01 |
EBITDA | -250.82M | -245.81M | -219.85M | -204.88M | -174.23M | -145.39M | -118.96M | -81.74M | -57.34M | -45.34M | -43.97M | -52.59M | -55.73M | -60.79M | -64.46M | -62.31M | -53.87M | -69.15M | -53.36M | -39.12M | -32.83M | -147.21K |
EBIT | -254.05M | -248.89M | -222.46M | -208.04M | -176.68M | -147.44M | -120.96M | -82.45M | -58.02M | -45.68M | -43.98M | -52.6M | -55.74M | -60.8M | -64.47M | -62.33M | -53.88M | -69.16M | -53.36M | -39.14M | -32.85M | -162.13K |
Depreciation & Amortization | 3.24M | 3.08M | 2.62M | 3.17M | 2.45M | 2.05M | 2M | 705.8K | 676.58K | 337.87K | 13.16K | 13.16K | 13.16K | 13.16K | 12.36K | 11.56K | 10.53K | 7.25K | 4.76K | 17.19K | 14.92K | 14.92K |
Add to Watchlist
Select watchlists to add or remove MLTX